Clobetasol promotes remyelination in a mouse model of neuromyelitis optica.
- Author(s): Verkman, Alan
- Yao, X
- Su, T
- Verkman, AS
- et al.
Published Web Locationhttp://europepmc.org/articles/PMC4845317?pdf=render
Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system that can produce marked neurological deficit. Current NMO therapies include immunosuppressants, plasma exchange and B-cell depletion. Here, we evaluated 14 po